Common mechanism of pathogenesis in various types of metastatic osteosarcoma

  • Authors:
    • Dongqi Wang
    • Zongrang Song
    • Zhan Wang
  • View Affiliations

  • Published online on: September 15, 2017     https://doi.org/10.3892/ol.2017.6955
  • Pages: 6307-6313
Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Abstract

The present study aimed to investigate the common metastatic mechanism in various types of metastatic osteosarcoma (OS). Gene expression profiles generated from the metastatic OS KHOS and KRIB cell lines and the non‑metastatic OS HOS cell line were compared. Two groups of differentially expressed genes (DEGs) between KHOS or KRIB and HOS were screened (P<0.01 and |fold change| ≥2) and then underwent Gene Ontology (GO) and pathway enrichment analyses. Subsequently, the protein‑protein interaction (PPI) network was constructed and the subnetwork was mined. Furthermore, overlapping DEGs of these two groups were identified and pathway enrichment and regulatory network analyses were performed. A total of 1,552 and 1,330 DEGs from KHOS vs. HOS and KRIB vs. HOS were obtained, respectively. GO and pathway enrichment analyses of DEGs between KRIB and HOS, including anatomical structure morphogenesis and focal adhesion, were similar to those between KHOS and HOS. Vascular endothelial growth factor A and epidermal growth factor receptor were hub nodes in the PPI network for KHOS and KRIB. Subnetworks of these two groups were similar. In addition, 421 upregulated and 595 downregulated overlapping genes were enriched in the mitogen‑activated protein kinase and transforming growth factor‑β signaling pathways. Furthermore, seven vital transcription factors, including hes‑related family bHLH transcription factor with YRPW motif 1 (HEY1), were obtained. Overall, different types of metastatic OS were shown to exhibit a similar mechanism of pathogenesis. With the exception of cell adhesion and angiogenesis, recapitulation of the morphogenetic processes facilitates OS tumor formation and metastasis. Genes such as HEY1 are important for metastatic OS. Further studies are required in order to confirm these results.

Introduction

Osteosarcoma (OS), which is one of the common primary bone tumors in children and adolescents is highly aggressive and metastatic (1); it comprises ~5% of all pediatric tumors and patients with pulmonary metastasis present a poor prognosis (2). There are definite differences in the mechanism between primary and metastatic OS, and numerous previous studies have been performed to expound them (35).

Multiple signaling pathways, including the Notch signaling pathway, are involved in cancer migration initiation through the extracellular matrix (ECM) towards the bloodstream (6). Survival of cancer cells in the bloodstream is mediated by the integrin signaling pathway to activate the phosphatidylinositol 3-kinase/protein kinase B survival pathway (7). Signaling pathways, including those of Src and Wnt, are involved in apoptosis resistance throughout metastasis (8,9). In addition, the immune system is also invaded and modulated for survival advantage (10). Subsequently, cell adhesion is arrested, and the cells extravasate to their new environment and re-establish cell-cell adhesions (11). There are numerous various viewpoints regarding the mechanism underlying metastatic tumor cell arrest to distant organ sites (12,13). Angiogenesis is necessary for cancer cell proliferation and metastasis (12); however, there remain a number of unknown mechanisms, including the precise mechanism underlying how cells alternate between exhibiting primary and metastatic properties.

Therefore, in the present study, gene expression profiles were used to further investigate the metastatic mechanism of OS. The GSE49003 dataset considered in the present study was previously analyzed by Diao et al (14) to identify differentially expressed genes (DEGs) between metastatic and non-metastatic patients with OS, and crucial microRNAs associated with OS metastasis, by merging data from different metastatic or non-metastatic OS cell lines. However, different types of metastatic OS may be regulated by different molecular mechanisms. In addition, transcription factors (TFs) may also serve a vital role in this pathomechanism. Therefore, the dataset was reanalyzed in the present study to emphasize the different mechanisms of different metastatic OS cell lines.

Materials and methods

Gene expression profile data

The raw expression data (dataset GSE49003; http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE49003), as provided by Endo-Munoz et al on July 18, 2013, were used in the present study. The microarray expression profile was obtained from two metastatic OS cell lines and two non-metastatic OS cell lines. The metastatic KHOS and KRIB cell lines and the non-metastatic HOS cell line were used with three-duplicated samples, and gene expression data from each of these cell lines were used. The platform of this dataset was GPL6847 Illumina HumanHT-12 V3.0 expression beadchip (Illumina Inc., San Diego, CA, USA).

Data preprocessing and DEG screening

The Limma package (15) in Bioconductor was used to add probe annotation files for each Illumina chip in order to preprocess the expression profile. Background correction, quantile normalization and probe summarization were performed to generate the gene expression data matrix.

DEGs between KHOS and HOS and between KRIB and HOS were determined using the Limma package. The differential expression of genes were analyzed by Student's t-test, and those with a false discovery rate adjusted P-value of <0.01 and |fold change| ≥2 were screened.

Functional enrichment analysis of DEGs

The Gene Ontology (GO) (16) project was established for gene classifications by molecular function, biological process (BP) and cellular component. DEGs of KHOS vs. HOS and KRIB vs. HOS were functionally enriched by GO. In addition, the Kyoto Encyclopedia of Genes and Genomes (KEGG) (17), which has a become a major database resource for understanding high-level functions of genes, was utilized. The default threshold of P<0.01 was selected for the hypergeometric enrichment test.

Protein-protein interaction (PPI) network construction and subnetwork mining

The Search Tool for the Retrieval of Interacting Genes/Proteins is a biological database that provides known and predicted PPIs (13). The tool was applied in the present study to identify interacting protein pairs between DEGs with a PPI score of 0.9. Subsequently, Cytoscape software version 2.8.0 (18) was used to visualize the constructed PPI network. Subnetworks (modules) with a hypergeometric P-value <0.05 were identified by the ClusterONE plugin (19) from Cytoscape. Furthermore, the Database for Annotation, Visualization and Integrated Discovery (20,21) was utilized to perform the KEGG pathway cluster analyses of DEGs in modules with P<0.05.

Overlapping gene analysis

Overlapping DEGs that were upregulated in KHOS and KRIB cells compared with HOS cells were identified, and downregulated DEGs that were common in KHOS and KRIB cells were identified. Thereafter, KEGG signaling pathways of these two types of overlapping genes were enriched.

Furthermore, based on the regulatory association between TFs and target genes recorded in the University of California Santa Cruz (UCSC) (22) database, regulatory associations between TFs and their target DEGs were identified.

Results

DEGs of various groups

A total of 1,552 (711 downregulated and 841 upregulated) and 1,330 DEGs (570 downregulated and 760 upregulated) were obtained from the KHOS vs. HOS and KRIB vs. HOS comparisons, respectively.

Functional enrichment analyses of DEGs

Significant enriched terms of GO and KEGG pathway enrichment analyses in KHOS and KRIB groups are presented in Tables I and II, respectively. Upregulated genes of KHOS were associated with GO-BP terms of anatomical structure morphogenesis and cellular response to extracellular stimulus, and the downregulated genes were enriched in BP terms of multicellular organismal development and anatomical structure morphogenesis. Using KEGG, focal adhesion, axon guidance and peroxisome proliferator-activated receptor signaling pathways were significantly enriched by upregulated genes of KHOS, and pathways in cancer, tight junctions and cell adhesion molecules were enriched by downregulated DEGs in KHOS cells (Table I). GO and pathway enrichment analyses of KRIB were similar to those of KHOS, and the significantly enriched GO term of KRIB overexpressed genes was anatomical structure morphogenesis, and the significantly enriched pathway was focal adhesion (Table II).

Table I.

Gene ontology and pathway enrichment analysis of genes in KHOS cells.

Table I.

Gene ontology and pathway enrichment analysis of genes in KHOS cells.

Category identityNameCountP-value
Upregulated genes
  GO:0009653Anatomical structure morphogenesis132 8.44×10−7
  GO:0031668Cellular response to extracellular stimulus  20 1.75×10−6
  GO:0031669Cellular response to nutrient levels  18 1.98×10−6
  GO:0071496Cellular response to external stimulus  24 2.72×10−6
  GO:0072358Cardiovascular system development  61 4.90×10−6
  Pathway:4510Focal adhesion  19 5.07×10−4
  Pathway:4360Axon guidance  14 7.61×10−4
  Pathway:250Alanine, aspartate and glutamate metabolism     6 1.66×10−3
  Pathway:3320PPAR signaling pathway     9 2.08×10−3
  Pathway:4512ECM-receptor interaction  10 2.35×10−3
Downregulated genes
  GO:0007275Multicellular organismal development3100.00
  GO:0009653Anatomical structure morphogenesis1920.00
  GO:0032502Developmental process3380.00
  GO:0044767Single-organism developmental process2850.00
  GO:0048468Cell development1580.00
  Pathway:5200Pathways in cancer  35 2.61×10−5
  Pathway:5146Amoebiasis  14 1.07×10−3
  Pathway:5144Malaria     9 1.08×10−3
  Pathway:4530Tight junction  16 1.24×10−3
  Pathway:4514Cell adhesion molecules  16 1.34×10−3

[i] Count, number of genes enriched in the functional term; GO, Gene Ontology; PPAR, peroxisome proliferator activated receptor; ECM; extracellular matrix.

Table II.

Gene ontology and pathway enrichment analysis of genes in KRIB cells.

Table II.

Gene ontology and pathway enrichment analysis of genes in KRIB cells.

Category identityNameCountP-value
Upregulated genes
  GO:0009653Anatomical structure morphogenesis106 3.88×10−6
  GO:0001944Vasculature development  38 9.85×10−6
  GO:0010646Regulation of cell communication108 1.24×10−5
  GO:0071294Cellular response to zinc ion     5 1.50×10−5
  GO:0023051Regulation of signaling107 1.88×10−5
  Pathway:4510Focal adhesion  16 7.36×10−4
  Pathway:480Glutathione metabolism     7 1.05×10−3
  Pathway:4360Axon guidance  11 3.03×10−3
  Pathway:3320PPAR signaling pathway     7 7.33×10−3
  Pathway:4520Adherens junction     7 9.19×10−3
Downregulated genes
  GO:0000902Cell morphogenesis1040.00
  GO:0000904Cell morphogenesis involved in differentiation  860.00
  GO:0006928Cellular component movement1320.00
  GO:0007275Multicellular organismal development2990.00
  GO:0007399Nervous system development1530.00
  Pathway:4514Cell adhesion molecules  19 1.14×10−5
  Pathway:5144Malaria  11 1.74×10−5
  Pathway:5146Amoebiasis  16 2.83×10−5
  Pathway:5200Pathways in cancer  32 4.49×10−5
  Pathway:4512ECM-receptor interaction  13 1.40×10−4

[i] Count, number of genes enriched in the functional term; GO, Gene Ontology; PPAR, peroxisome proliferator activated receptor; ECM; extracellular matrix.

PPI network and subnetwork

A total of 856 pairs of interacting proteins and 495 nodes were noted in the PPI network of KHOS (Fig. 1A). The top 6 nodes with a greater degree of connectivity compared with the others were jun proto-oncogene (JUN; degree=33), vascular endothelial growth factor A (VEGFA; degree=29), epidermal growth factor receptor (EGFR; degree=23), cyclin-dependent kinase inhibitor 1A (degree=19), interleukin 6 (IL-6; degree=19) and signal transducer and activator of transcription 3 (STAT3; degree=17). Furthermore, two modules with P<0.05 were obtained (Fig. 1B and C). A total of 9 genes, including 7 collagen molecules and 2 integrin family members involved in module 1 were significantly enriched in terms of ECM-receptor interaction and focal adhesion.

There were 719 interacting pairs and 397 nodes of the PPI network of KRIB (Fig. 2). VEGFA (degree=29), Fyn oncogene related to Src, FGR, Yes (degree=25), JUN (degree=23), EGFR (degree=22) and IL-6 (degree=19), were the top 5 hub nodes. In addition, one module was screened (Fig. 2), and the significant pathways enriched by its genes were ECM-receptor interaction and focal adhesion.

KEGG pathway enrichment and transcriptional regulatory network analysis of overlapping DEGs

A total of 421 upregulated and 595 downregulated overlapping genes were obtained. Pathway of focal adhesion, glutathione metabolism and endocytosis were enriched by their upregulated genes, whereas pathways in cancer, focal adhesion and cell adhesion molecules were enriched by downregulated genes. In addition, the mitogen-activated protein kinase (MAPK) and transforming growth factor-β (TGF-β) signaling pathways were enriched by overlapping genes with decreased expression levels (Table III).

Table III.

Kyoto Encyclopedia of genes and genomes pathway of overlapping genes.

Table III.

Kyoto Encyclopedia of genes and genomes pathway of overlapping genes.

Category identityNameCountP-value
Upregulated overlapping gene
  4510Focal adhesion13 2.96×10−3
  480Glutathione metabolism  5 3.11×10−2
  4144Endocytosis10 3.18×10−2
  4360Axon guidance  8 3.46×10−2
  4520Adherens junction  6 3.67×10−2
Downregulated overlapping gene
  5200Pathways in cancer27 2.52×10−4
  4510Focal adhesion17 3.93×10−3
  4514Cell adhesion molecules13 4.25×10−3
  4512ECM-receptor interaction10 4.40×10−3
  4010MAPK signaling pathway19 1.26×10−2
  4350TGF-β signaling pathway  9 1.72×10−2

[i] Count, number of genes enriched in the functional term; ECM, extracellular matrix; MAPK, mitogen-activated protein kinase; transforming growth factor-β.

Fig. 3 demonstrates the transactional regulatory network of overlapping DEGs. A total of 7 TFs, including activating transcription factor 3, forkhead box (FOX)A1, STAT3, FOXA2, hes-related family bHLH transcription factor with YRPW motif 1 (HEY1), SUZ12 polycomb repressive complex 2 subunit and zinc finger ZZ-type containing 3 were identified. The first three of these were downregulated and the others were overexpressed.

Discussion

Due to the high risk for recurrence and the poor survival of metastatic OS patients (23), two different metastatic OS cell lines and one non-metastatic cell lines were used to investigate the mechanism underlying metastasis. The GO and pathway enrichment analysis results were similar of these two metastatic types of OS. Besides, a large number of overlapping genes, including 7 TFs, were obtained. These genes and biological functions may be important in OS tumor metastasis.

The most prominent node in the PPI networks of KHOS and KRIB was VEGFA, which is a growth factor that is activated in vasculogenesis, angiogenesis and endothelial cell growth (24). It is not only a commonly upregulated angiogenic factor during tumor growth, but also the most frequent lymphangiogenic factor contributing to the lymphatic metastasis (25). A previous study suggested that VEGFA promoted tumor growth and metastasis via the VEGF-VEGFR1 signaling pathway (26). In addition, EGFR, which is a member of the EGF family, was another common hub node with a high degree (27). It was revealed that EGFR participated in the promotion of cell division, migration and angiogenesis, and inhibited cell apoptosis (28). Furthermore, these two genes were enriched in the development and differentiation process, including anatomical structure morphogenesis and vasculature development. Yang et al (29) demonstrated that Twist, which is a master regulator of embryonic morphogenesis, contributed to metastasis by promoting an epithelial-mesenchymal transition (29). Therefore, tumor metastasis is the recapitulation of morphogenetic processes (30). Morphogenetic factors, including hepatocyte growth factor/scatter factor have metastasis-promoting effects on breast carcinoma cells (31). Based on these studies, VEGFA and EGFR may be factors involved in the morphogenetic processes to promote tumor metastasis.

The KEGG pathway enrichment analysis results of module 1 of the KHOS group was similar to that of module 1 of the KRIB group. ECM-receptor interaction and focal adhesion were the observed pathways enriched by multiple collagen genes and integrin genes. These results were in accordance with previous studies (32,33) and demonstrated the accuracy and practicability of them. Additionally, functional enrichment analysis of overlapping genes of these two group would be more direct to exhibit commonality of metastatic OS.

Focal adhesion was the significant pathway enriched by upregulated and downregulated overlapping genes. Furthermore, these downregulated genes remained enriched in signaling pathways that included the MAPK and TGF-β signaling pathways. The former pathway serves an important role in the early metastasis of the tumor (34,35), whereas the latter has positive and negative effects on carcinogenesis (36), and further investigation for is required to fully elucidate the molecular mechanism.

Finally, a total of 7 TFs, which regulated multiple genes, were screened. Among them, FOXA1, STAT3 and HEY1 were more important in the regulatory network. Candy et al (37) indicated that overexpressed HEY1 was a negative prognostic factor for colorectal cancer, and it is closely associated with vascular and perineural invasion and lymph node metastasis. Therefore, the upregulated HEY1 may be associated with OS metastasis. In addition, FOXA1 was revealed to be a participant in embryonic development, mediating tissue-specific gene expression in differentiated tissues (38). This gene encoded protein may be another important factor involved in the similar process of morphogenesis.

In conclusion, recapitulation of morphogenetic processes, a disordered signaling system, and activated cell adhesion and migration were involved in the facilitated tumor metastasis. Furthermore, morphogenesis and vasculature development induced angiogenesis, and tumor growth and adhesion, or even the lymph node metastasis induced the metastatic OS. The present study further illustrated the OS tumorigenesis mechanism and displayed the crucial roles of genes such as VEGFA, EGFR and HEY1. The practical clinical significance has not yet been clearly described and requires further investigation.

References

1 

Wu J, Hsieh MY, Wang Y, Roberts E, Vallejo D, Lee A and Ermel R: Antitumor properties of ouabain in lipid double emulsion in orthotopic canine osteosarcoma xenografted mouse model. Cancer Res. 74:54122014. View Article : Google Scholar

2 

Roos A, Yustein JT and Donehower L: Oncogenic role of Runx2 in the development of osteosarcoma. Cancer Res. 73:5036. 2013. View Article : Google Scholar

3 

Pompetti F, Rizzo P, Simon RM, Freidlin B, Mew DJ, Pass HI, Picci P, Levine AS and Carbone M: Oncogene alterations in primary, recurrent, and metastatic human bone tumors. J Cell Biochem. 63:37–50. 1996. View Article : Google Scholar : PubMed/NCBI

4 

Oda Y, Naka T, Takeshita M, Iwamoto Y and Tsuneyoshi M: Comparison of histological changes and changes in nm23 and c-MET expression between primary and metastatic sites in osteosarcoma: A clinicopathologic and immunohistochemical study. Human Pathol. 31:709–716. 2000. View Article : Google Scholar

5 

Liang S, Ren Z, Han X, Yang J, Shan L, Li L, Wang B, Zhang Q, Mu T, Chen K, et al: PLA2G16 expression in human osteosarcoma is associated with pulmonary metastasis and poor prognosis. PLoS One. 10:e01272362015. View Article : Google Scholar : PubMed/NCBI

6 

Hughes DP: How the NOTCH pathway contributes to the ability of osteosarcoma cells to metastasizePediatric and Adolescent Osteosarcoma. Jaffe N, Bruland OS and Bielack S: 152. Springer; New York, NY: pp. 479–496. 2010, View Article : Google Scholar

7 

Casar B, Rimann I, Kato H, Shattil SJ, Quigley JP and Deryugina EI: In vivo cleaved CDCP1 promotes early tumor dissemination via complexing with activated β1 integrin and induction of FAK/PI3K/Akt motility signaling. Oncogene. 33:255–268. 2012. View Article : Google Scholar : PubMed/NCBI

8 

Kim LC, Song L and Haura EB: Src kinases as therapeutic targets for cancer. Nat Rev Clin Oncol. 6:587–595. 2009. View Article : Google Scholar : PubMed/NCBI

9 

Rubin EM, Guo Y, Tu K, Xie J, Zi X and Hoang BH: Wnt inhibitory factor 1 decreases tumorigenesis and metastasis in osteosarcoma. Mol Cancer Ther. 9:731–741. 2010. View Article : Google Scholar : PubMed/NCBI

10 

Krishnan K, Khanna C and Helman LJ: The biology of metastases in pediatric sarcomas. Cancer J. 11:306–313. 2005. View Article : Google Scholar : PubMed/NCBI

11 

Eccles SA and Welch DR: Metastasis: Recent discoveries and novel treatment strategies. Lancet. 369:1742–1757. 2007. View Article : Google Scholar : PubMed/NCBI

12 

Fidler IJ: The pathogenesis of cancer metastasis: The ‘seed and soil’ hypothesis revisited. Nat Rev Cancer. 3:453–458. 2003. View Article : Google Scholar : PubMed/NCBI

13 

Steeg PS: Tumor metastasis: Mechanistic insights and clinical challenges. Nat Med. 12:895–904. 2006. View Article : Google Scholar : PubMed/NCBI

14 

Diao CY, Guo HB, Ouyang YR, Zhang HC, Liu LH, Bu J, Wang ZH and Xiao T: Screening for metastatic osteosarcoma biomarkers with a DNA microarray. Asian Pac J Cancer Prev. 15:1817–1822. 2013. View Article : Google Scholar

15 

Smyth GK: Limma: Linear models for microarray dataBioinformatics and computational biology solutions using R and Bioconductor. Gentleman R, Carey VJ, Huber W, Irizarry RA and Dudoit S: Springer; New York: pp. 397–420. 2005, View Article : Google Scholar

16 

Ashburner M, Ball CA, Blake JA, Botstein D, Butler H, Cherry JM, Davis AP, Dolinski K, Dwight SS, Eppig JT, et al: Gene Ontology: Tool for the unification of biology. The Gene Ontology Consortium. Nat Genet. 25:25–29. 2000. View Article : Google Scholar : PubMed/NCBI

17 

Kanehisa M and Goto S: KEGG: Kyoto encyclopedia of genes and genomes. Nucleic Acids Res. 28:27–30. 2000. View Article : Google Scholar : PubMed/NCBI

18 

Shannon P, Markiel A, Ozier O, Baliga NS, Wang JT, Ramage D, Amin N, Schwikowski B and Ideker T: Cytoscape: A software environment for integrated models of biomolecular interaction networks. Genome Res. 13:2498–2504. 2003. View Article : Google Scholar : PubMed/NCBI

19 

Nepusz T, Yu H and Paccanaro A: Detecting overlapping protein complexes in protein-protein interaction networks. Nat Methods. 9:471–472. 2012. View Article : Google Scholar : PubMed/NCBI

20 

da Huang W, Sherman BT and Lempicki RA: Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources. Nat Protoc. 4:44–57. 2008. View Article : Google Scholar

21 

da Huang W, Sherman BT and Lempicki RA: Bioinformatics enrichment tools: Paths toward the comprehensive functional analysis of large gene lists. Nucleic Acids Res. 37:1–13. 2009. View Article : Google Scholar : PubMed/NCBI

22 

Meyer LR, Zweig AS, Hinrichs AS, Karolchik D, Kuhn RM, Wong M, Sloan CA, Rosenbloom KR, Roe G, Rhead B, et al: The UCSC Genome Browser database: Extensions and updates 2013. Nucleic Acids Res. 41:(Database issue). D64–D69. 2013. View Article : Google Scholar : PubMed/NCBI

23 

PosthumaDeBoer J, Witlox MA, Kaspers GJ and Van Royen BJ: Molecular alterations as target for therapy in metastatic osteosarcoma: A review of literature. Clin Exp Metastasis. 28:493–503. 2011. View Article : Google Scholar : PubMed/NCBI

24 

Liang D, Chang JR, Chin AJ, Smith A, Kelly C, Weinberg ES and Ge R: The role of vascular endothelial growth factor (VEGF) in vasculogenesis, angiogenesis, and hematopoiesis in zebrafish development. Mech Dev. 108:29–43. 2001. View Article : Google Scholar : PubMed/NCBI

25 

Björndahl MA, Cao R, Burton JB, Brakenhielm E, Religa P, Galter D, Wu L and Cao Y: Vascular endothelial growth factor-a promotes peritumoral lymphangiogenesis and lymphatic metastasis. Cancer Res. 65:9261–9268. 2005. View Article : Google Scholar : PubMed/NCBI

26 

Liu W, Xu J, Wang M, Wang Q, Bi Y and Han M: Tumor-derived vascular endothelial growth factor (VEGF)-A facilitates tumor metastasis through the VEGF-VEGFR1 signaling pathway. Int J Oncol. 39:1213–1220. 2011.PubMed/NCBI

27 

Zimmermann M, Zouhair A, Azria D and Ozsahin M: The epidermal growth factor receptor (EGFR) in head and neck cancer: Its role and treatment implications. Radiation Oncol. 1:112006. View Article : Google Scholar

28 

Italiano A, Saint-Paul MC, Caroli-Bosc FX, François E, Bourgeon A, Benchimol D, Gugenheim J and Michiels JF: Epidermal growth factor receptor (EGFR) status in primary colorectal tumors correlates with EGFR expression in related metastatic sites: Biological and clinical implications. Ann Oncol. 16:1503–1507. 2005. View Article : Google Scholar : PubMed/NCBI

29 

Yang J, Mani SA, Donaher JL, Ramaswamy S, Itzykson RA, Come C, Savagner P, Gitelman I, Richardson A and Weinberg RA: Twist, a master regulator of morphogenesis, plays an essential role in tumor metastasis. Cell. 117:927–939. 2004. View Article : Google Scholar : PubMed/NCBI

30 

Berx G, Raspé E, Christofori G, Thiery JP and Sleeman JP: Pre-EMTing metastasis? Recapitulation of morphogenetic processes in cancer. Clin Exp Metastasis. 24:587–597. 2007. View Article : Google Scholar : PubMed/NCBI

31 

Meiners S, Brinkmann V, Naundorf H and Birchmeier W: Role of morphogenetic factors in metastasis of mammary carcinoma cells. Oncogene. 16:9–20. 1998. View Article : Google Scholar : PubMed/NCBI

32 

Lu P, Weaver VM and Werb Z: The extracellular matrix: A dynamic niche in cancer progression. J Cell Biol. 196:395–406. 2012. View Article : Google Scholar : PubMed/NCBI

33 

Felding-Habermann B: Integrin adhesion receptors in tumor metastasis. Clin Exp Metastasis. 20:203–213. 2003. View Article : Google Scholar : PubMed/NCBI

34 

Khanna C, Wan X, Bose S, Cassaday R, Olomu O, Mendoza A, Yeung C, Gorlick R, Hewitt SM and Helman LJ: The membrane-cytoskeleton linker ezrin is necessary for osteosarcoma metastasis. Nat Med. 10:182–186. 2004. View Article : Google Scholar : PubMed/NCBI

35 

Wan X, Mendoza A, Khanna C and Helman LJ: Rapamycin inhibits ezrin-mediated metastatic behavior in a murine model of osteosarcoma. Cancer Res. 65:2406–2411. 2005. View Article : Google Scholar : PubMed/NCBI

36 

Derynck R, Akhurst RJ and Balmain A: TGF-beta signaling in tumor suppression and cancer progression. Nat Genet. 29:117–129. 2001. View Article : Google Scholar : PubMed/NCBI

37 

Candy P, Phillips MR, Redfern AD, Colley SM, Davidson JA, Stuart LM, Wood BA, Zeps N and Leedman PJ: Notch-induced transcription factors are predictive of survival and 5-fluorouracil response in colorectal cancer patients. Br J Cancer. 109:1023–1030. 2013. View Article : Google Scholar : PubMed/NCBI

38 

Bernardo GM and Keri RA: FOXA1: A transcription factor with parallel functions in development and cancer. Biosci Rep. 32:113–130. 2012. View Article : Google Scholar : PubMed/NCBI

Related Articles

Journal Cover

November-2017
Volume 14 Issue 5

Print ISSN: 1792-1074
Online ISSN:1792-1082

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
x
Spandidos Publications style
Wang D, Song Z and Wang Z: Common mechanism of pathogenesis in various types of metastatic osteosarcoma. Oncol Lett 14: 6307-6313, 2017
APA
Wang, D., Song, Z., & Wang, Z. (2017). Common mechanism of pathogenesis in various types of metastatic osteosarcoma. Oncology Letters, 14, 6307-6313. https://doi.org/10.3892/ol.2017.6955
MLA
Wang, D., Song, Z., Wang, Z."Common mechanism of pathogenesis in various types of metastatic osteosarcoma". Oncology Letters 14.5 (2017): 6307-6313.
Chicago
Wang, D., Song, Z., Wang, Z."Common mechanism of pathogenesis in various types of metastatic osteosarcoma". Oncology Letters 14, no. 5 (2017): 6307-6313. https://doi.org/10.3892/ol.2017.6955